- Home
- CMTL vs AVTX Comparison
CMTL vs AVTX Comparison
Compare CMTL & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMTL
- AVTX
- Stock Information
- Founded
- CMTL 1967
- AVTX 2011
- Country
- CMTL United States
- AVTX United States
- Employees
- CMTL N/A
- AVTX N/A
- Industry
- CMTL Radio And Television Broadcasting And Communications Equipment
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- CMTL Technology
- AVTX Health Care
- Exchange
- CMTL Nasdaq
- AVTX Nasdaq
- Market Cap
- CMTL 58.2M
- AVTX 57.4M
- IPO Year
- CMTL N/A
- AVTX 2015
- Fundamental
- Price
- CMTL $2.42
- AVTX $4.76
- Analyst Decision
- CMTL Strong Buy
- AVTX Strong Buy
- Analyst Count
- CMTL 1
- AVTX 7
- Target Price
- CMTL $6.00
- AVTX $31.00
- AVG Volume (30 Days)
- CMTL 398.9K
- AVTX 103.2K
- Earning Date
- CMTL 06-09-2025
- AVTX 08-11-2025
- Dividend Yield
- CMTL N/A
- AVTX N/A
- EPS Growth
- CMTL N/A
- AVTX N/A
- EPS
- CMTL N/A
- AVTX N/A
- Revenue
- CMTL $495,352,000.00
- AVTX $441,000.00
- Revenue This Year
- CMTL N/A
- AVTX N/A
- Revenue Next Year
- CMTL N/A
- AVTX N/A
- P/E Ratio
- CMTL N/A
- AVTX $0.71
- Revenue Growth
- CMTL N/A
- AVTX N/A
- 52 Week Low
- CMTL $1.19
- AVTX $3.39
- 52 Week High
- CMTL $5.16
- AVTX $16.00
- Technical
- Relative Strength Index (RSI)
- CMTL 58.35
- AVTX 54.23
- Support Level
- CMTL $2.34
- AVTX $4.50
- Resistance Level
- CMTL $2.77
- AVTX $5.02
- Average True Range (ATR)
- CMTL 0.26
- AVTX 0.36
- MACD
- CMTL 0.02
- AVTX 0.05
- Stochastic Oscillator
- CMTL 65.09
- AVTX 72.92
About CMTL Comtech Telecommunications Corp.
Comtech Telecommunications Corp is a provider of modern communications solution incorporated in USA. The company is engaged in designing, developing, producing and marketing products, systems, and services for communications solutions. It is engaged in two business segments, Satellite and Space Communications and Terrestrial and Wireless Networks. It's Space and satellite is USA based providers of modems and high-power amplifiers, a market leader in troposcatter technologies, and serves some of the world's defense contractors and allied foreign governments. Terrestrial and Wireless Networks segment is a provider of next generation 911 infrastructure and solutions for state and local governments and carriers. Majority of sales are generated from Satellite and Space Communications segment.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).